Ailsa K. Holroyd
Institute of Cancer Research(GB)Cancer Research UK(GB)
Publications by Year
Research Areas
FOXO transcription factor regulation, Chronic Lymphocytic Leukemia Research, PI3K/AKT/mTOR signaling in cancer, Lymphoma Diagnosis and Treatment, Renal Diseases and Glomerulopathies
Most-Cited Works
- → A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1(2016)85 cited
- → Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning(2013)61 cited
- → The role of mTOR-mediated signaling in the regulation of cellular migration(2018)36 cited
- → Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk(2014)34 cited
- → AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival(2018)33 cited
- → The two faces of myeloproliferative neoplasms: Molecular events underlying lymphoid transformation(2011)11 cited
- → Generation of a poor prognostic chronic lymphocytic leukemia-like disease model: PKC subversion induces up-regulation of PKC II expression in B lymphocytes(2015)11 cited
- → Collaboration of MYC and RUNX2 in lymphoma simulates T‐cell receptor signaling and attenuates p53 pathway activity(2019)8 cited
- → Runs of homozygosity and testicular cancer risk(2019)7 cited
- → PKCβ Facilitates Leukemogenesis in Chronic Lymphocytic Leukaemia by Promoting Constitutive BCR-Mediated Signalling(2022)4 cited